Suchergebnisse - "Lypressin adverse effects"

Hepatorenalt syndrom:Diagnose, behandling og forebyggelse: Diagnose, behandling og forebyggelse

Autoren: Egerod Israelsen, Mads Gluud, Lise Lotte Bendtsen, Flemming et al.

Quelle: Israelsen, M E, Gluud, L L, Bendtsen, F, Krag, A A & Møller, S 2013, ' Hepatorenalt syndrom : Diagnose, behandling og forebyggelse ', Ugeskrift for Laeger, bind 175, nr. 22, s. 1562-1565 .

Schlagwörter: Vasoconstrictor Agents/adverse effects, Evidence-Based Medicine, Lypressin/adverse effects, Albumins/therapeutic use, Kidney/drug effects, Ascites/diagnosis, 3. Good health, Liver Transplantation, Hepatorenal Syndrome/diagnosis, Drug Therapy, Liver Cirrhosis/complications, Combination, Transjugular Intrahepatic, Humans, Drug Therapy, Combination, Portasystemic Shunt, Portasystemic Shunt, Transjugular Intrahepatic, Terlipressin

Zugangs-URL: https://portal.findresearcher.sdu.dk/da/publications/536f95fb-9de9-4a95-8dc5-3eb351bae8f4

Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome

Autoren: Allegretti, Andrew S. Israelsen, Mads Krag, Aleksander et al.

Quelle: Allegretti, A S, Israelsen, M, Krag, A, Jovani, M, Goldin, A H, Schulman, A R, Winter, R W & Gluud, L L 2017, 'Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome', Cochrane Database of Systematic Reviews, vol. 6, no. 6, CD005162. https://doi.org/10.1002/14651858.CD005162.pub4

Schlagwörter: Abdominal Pain/chemically induced, Albumins/therapeutic use, Diarrhea/chemically induced, Hepatorenal Syndrome/classification, Humans, Lypressin/adverse effects, Randomized Controlled Trials as Topic, Terlipressin, Vasoconstrictor Agents/adverse effects

Dateibeschreibung: application/pdf

Verfügbarkeit: https://portal.findresearcher.sdu.dk/da/publications/61290215-60cd-43d2-818a-de6ae9514794
https://doi.org/10.1002/14651858.CD005162.pub4
https://findresearcher.sdu.dk/ws/files/137924747/Allegretti_et_al_2017_.pdf

Terlipressin versus other vasoactive drugs for hepatorenal syndrome

Autoren: Israelsen, Mads Krag, Aleksander Allegretti, Andrew S. et al.

Quelle: Israelsen, M, Krag, A, Allegretti, A S, Jovani, M, Goldin, A H, Winter, R W & Gluud, L L 2017, 'Terlipressin versus other vasoactive drugs for hepatorenal syndrome', Cochrane Database of Systematic Reviews, vol. 2017, no. 9, CD011532. https://doi.org/10.1002/14651858.CD011532.pub2

Schlagwörter: Antihypertensive Agents/adverse effects, Dopamine/therapeutic use, Hepatorenal Syndrome/drug therapy, Humans, Lypressin/adverse effects, Midodrine/therapeutic use, Norepinephrine/therapeutic use, Octreotide/therapeutic use, Randomized Controlled Trials as Topic, Terlipressin, Vasoconstrictor Agents/adverse effects

Dateibeschreibung: application/pdf

Verfügbarkeit: https://portal.findresearcher.sdu.dk/da/publications/4c97d672-4225-4fbd-ba23-7893972b9256
https://doi.org/10.1002/14651858.CD011532.pub2
https://findresearcher.sdu.dk/ws/files/137924773/Israelsen_et_al_2017_.pdf

Severe hyponatraemia in terlipressin treatment / Svaer hyponatriaemi ved terlipressinbehandling

Autoren: Poulsen, Anja Krag, Aleksander

Quelle: Ugeskrift for Laeger. 175(39):2250

Genital Ischemia in a Patient Under Terlipressin Therapy

Autoren: Samuel Raimundo Fernandes Cilénia Baldaia Ana Rita Gonçalves

Quelle: GE: Portuguese Journal of Gastroenterology, Vol 23, Iss 4, Pp 224-225 (2016)

Schlagwörter: Ischemia, Lypressin/adverse effects, Diseases of the digestive system. Gastroenterology, RC799-869

Relation: http://www.sciencedirect.com/science/article/pii/S2341454515001428; https://doaj.org/toc/2341-4545; https://doaj.org/article/c09dac81c3c94247820221deebeead8f

Verfügbarkeit: https://doi.org/10.1016/j.jpge.2015.11.001
https://doaj.org/article/c09dac81c3c94247820221deebeead8f

Bleeding esophageal varices and hemoglobin 1,6 g/dl / Blödande esofagusvaricer och hemoglobin 1,6 g/dl

Autoren: Kretschmar, Gerold Andersson, Elisabeth

Quelle: Scandinavian Update Magazine. 2(4):18

Hepatorenalt syndrom:Diagnose, behandling og forebyggelse ; Hepatorenal syndrome:diagnosis, treatment and prevention.

Autoren: Israelsen, Mads Egerod Gluud, Lise Lotte Bendtsen, Flemming et al.

Quelle: Israelsen, M E, Gluud, L L, Bendtsen, F, Krag, A A & Møller, S 2013, 'Hepatorenalt syndrom : Diagnose, behandling og forebyggelse', Ugeskrift for Læger, bind 175, nr. 22, s. 1562-1565.

Schlagwörter: Albumins/therapeutic use, Ascites/diagnosis, Drug Therapy, Combination, Evidence-Based Medicine, Hepatorenal Syndrome/diagnosis, Humans, Kidney/drug effects, Liver Cirrhosis/complications, Liver Transplantation, Lypressin/adverse effects, Portasystemic Shunt, Transjugular Intrahepatic, Terlipressin, Vasoconstrictor Agents/adverse effects

Verfügbarkeit: https://portal.findresearcher.sdu.dk/da/publications/536f95fb-9de9-4a95-8dc5-3eb351bae8f4

Hepatorenal syndrome: diagnosis, treatment and prevention / Hepatorenalt syndrom: diagnose, behandling og forebyggelse

Autoren: Egerod Israelsen, Mads Gluud, Lise Lotte Bendtsen, Flemming et al.

Quelle: Ugeskrift for Laeger. 175(22):1562